New Rotavirus Vaccine Is More Protective in Children
A new vaccine to protect against rotavirus has been developed by Serum Institute of India.
Intravenous Immune Globulin Improves Systemic Sclerosis Symptoms
Administration of high-dose intravenous immune globulin (IVIG) significantly improved muscle and joint pain, muscle weakness and markers of systemic inflammation, according to a retrospective evaluation of 46 systemic sclerosis patients at 19 French centers.
Study Finds New Subset of T Cells That Drive Inflammation in Peripheral Tissues
Researchers at Brigham and Women’s Hospital have discovered a subset of T cells that collaborate with other immune cells to drive inflammation in peripheral tissues.
Vaccine in Development for Early-Stage Breast Cancer
Researchers at the Moffitt Cancer Center are developing a new vaccine that will help early-stage breast cancer patients who have HER2 positive disease.
Study Shows Frog Slime Can Kill Flu Viruses
Researchers have identified a peptide in the mucus secreted by a South Indian frog that can kill certain types of flu viruses.
Study Finds Blood Plasma Can Restore Brain Function
Results from a new study show that brain function can be restored by human blood plasma.
Type 2 Diabetes Patients Have Higher Prevalence of Chronic Hepatitis B
A study has found that patients with type 2 diabetes have a higher prevalence of chronic hepatitis B virus infection.
Hemophilia B Gene Therapy Is Effective Despite Immune Reactions
A PhaseI/II study of nine patients with hemophilia B who underwent Spark Therapeutics’ SPK-9001 gene therapy are promising, despite two adverse autoimmune reactions.
Study Shows High Prevalence of Anti-TSH Receptor Antibody in Fibromyalgia
A study has found that patients with fibromyalgia have a high prevalence of anti-thyroid-stimulating hormone receptor antibody.
C.Diff Vaccine Shows Promise in Phase II Trial
Results of a Phase II clinical trial ofPfizer’s preventive vaccine againstClostridium difficile (C. diff) showed the vaccine was safe and stimulated a C. diff targeted immune response.
